Previous close | 17.64 |
Open | 18.27 |
Bid | 14.50 |
Ask | 20.10 |
Strike | 105.00 |
Expiry date | 2026-01-16 |
Day's range | 17.45 - 18.75 |
Contract range | N/A |
Volume | |
Open interest | 299 |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.